NCT07281833 2026-02-27
CAPIcorn
West German Study Group
Phase 3 Recruiting
Clinical Trials
4 trialsNCT02423603 2025-03-10
PAKT
Queen Mary University of London
Phase 2 Completed
NCT05348577 2025-01-27
CAPItello280
AstraZeneca
Phase 3 Active not recruiting
NCT04087174 2022-07-13
A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate Cancer
AstraZeneca
Phase 1 Completed